Southland Equity Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Southland Equity Partners's MRK Position: Q2 2026 in Review
Southland Equity Partners increased its Merck (MRK) stake by 17% in Q2 2026, buying an estimated $37.1K and bringing the position to 2,154 shares worth $277K. The position accounts for 0.05% of the portfolio, ranked #247.
Southland Equity Partners first reported a position in MRK in Q1 2024 and has held it in 4 quarters since. 1,561 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Southland Equity Partners held 2,154 shares of Merck worth $277K as of Q2 2026.
- Southland Equity Partners bought 317 Merck shares in Q2 2026, an estimated $37.1K.
- Merck made up 0.05% of Southland Equity Partners's portfolio in Q2 2026, its #247 holding.
- Southland Equity Partners first reported a position in Merck in Q1 2024 and has held it in 4 quarters since.
- 1,561 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.